- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00742677
Feeding Schedules After Surgery in Patients With Gynecologic Cancer
Early Oral Feeding After a Gynaecologic Oncologic Laparotomy: A Randomized Controlled Trial
RATIONALE: Abdominal pain and nausea and vomiting may be lessened by waiting after surgery before eating foods by mouth. It is not yet known which feeding schedule is more effective in patients undergoing surgery.
PURPOSE: This randomized clinical trial is comparing two feeding schedules after laparotomy in patients with gynecologic cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVES:
Primary
- To investigate the relationship between the different policies of realimentation (early oral feedings versus traditional feedings) and the length of hospital stay following a laparotomy in patients with gynecologic oncologic disease.
- To assess the degree of postoperative abdominal pain in these patients.
- To evaluate the incidence of ileus symptoms, including nausea and vomiting, and the postoperative recovery of intestinal activity in these patients.
- To determine the incidence of postoperative complications in these patients.
- To elucidate the global postoperative patient's satisfaction and the quality of life in both groups of patients.
OUTLINE: Patients are stratified according to laparotomy with or without intestinal resection (yes vs no), and presence of ovarian cancer (yes vs no). Patients are randomized to 1 of 2 groups at the end of surgery.
- Group 1 (early feeding): Patients are offered a liquid diet on day 1 for 24 hours following surgery. Beginning on day 2, patients who tolerate a liquid diet are offered a regular diet until hospital discharge.
- Group 2 (traditional feeding): Patients are offered nothing by mouth on days 1 and 2 following surgery. Beginning on day 3, patients are offered a liquid diet for 24 hours. Beginning on day 4, patients who tolerate a liquid diet (i.e., no nausea and vomiting) are offered a semi-solid diet for 24 hours. Beginning on day 5, patients who tolerate a semi-solid diet are offered a light regular diet until hospital discharge.
Data is collected through the Post-Operative Pain Questionnaire, Bowel Function Table, Global Postoperative Patient's Satisfaction Questionnaire, Postoperative Complication and Hospital Stay Questionnaire, and the Quality of Life Questionnaires EORTC OV-28 and EORTC QLQ-C30.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Milan, Italy, 20141
- European Institute of Oncology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
DISEASE CHARACTERISTICS:
Preoperative diagnosis for probable gynecologic pathology
- No benign pathology or final histopathology diagnosis confirmed as non-gynecologic disease
- Admitted to the European Institute of Oncology
Elected to undergo laparotomic surgery
- No total or anterior pelvic exenteration
- No emergency laparotomy
PATIENT CHARACTERISTICS:
- No metabolic pathology (e.g., diabetes mellitus type I)
- No preoperative ASA score ≥ 4
- No preoperative infection
- No severe malnutrition (weight loss > 10% within the past 3 months)
- No preoperative intestinal obstruction
- No postoperative admission to the intensive care unit (ICU) for more than 24 hours
- No severe concomitant medical condition
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior abdominal and/or pelvis radiotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1 (early feeding)
Patients are offered a liquid diet on day 1 for 24 hours following surgery.
Beginning on day 2, patients who tolerate a liquid diet are offered a light regular diet until hospital discharge.
|
Given orally
|
Active Comparator: Group 2 (traditional feeding)
Patients are offered nothing by mouth on days 1 and 2 following surgery.
Beginning on day 3, patients are offered a liquid diet for 24 hours.
Beginning on day 4, patients who tolerate a liquid diet (absence of nausea and vomiting) are offered a semi-solid diet for 24 hours.
Beginning on day 5, patients who tolerate a semi-solid diet are offered a light regular diet until hospital discharge.
|
Given orally
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Length of hospital stay
|
Secondary Outcome Measures
Outcome Measure |
---|
Postoperative complications
|
Incidence of symptoms of postoperative ileus (e.g., nausea, vomiting, time to feel intestinal activity, time to passage of flatus, and time to bowel movement)
|
Degree of postoperative abdominal pain
|
Global postoperative patient satisfaction
|
Quality of life using the EORTC OV-28 and EORTC QLQ-C30 questionnaires at baseline and at day 30
|
Postoperative requirement of antiemetic and analgesic medication
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lucas Minig, MD, European Institute of Oncology
- Principal Investigator: Angelo Maggioni, MD, European Institute of Oncology
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CDR0000612328
- IEO-S328/506
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female Reproductive Cancer
-
Pennington Biomedical Research CenterCompletedFemale Reproductive Problem | Male Reproductive ProblemUnited States
-
University Hospital, ToulouseTerminatedFemale Reproductive Problem | Male Reproductive ProblemsFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Metastatic Cervical CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingFemale Reproductive CancerUnited States
-
Queensland Centre for Gynaecological CancerCompletedFemale Reproductive ProblemAustralia
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingMetastatic Malignant Female Reproductive System Neoplasm | Platinum-Resistant Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System NeoplasmUnited States
-
University of SaskatchewanCanadian Institutes of Health Research (CIHR)Completed
-
Tata Memorial CentreTerminatedGastrointestinal Cancer | Malignant Female Reproductive System Neoplasm | Urological CancerIndia
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedFemale Reproductive CancerUnited States
-
Advocate Health CareTerminatedBenign Female Reproductive System NeoplasmUnited States
Clinical Trials on nutritional support
-
Boston Medical CenterThe International Union Against Tuberculosis and Lung DiseaseRecruiting
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Project...Completed
-
Peking Union Medical CollegeNot yet recruiting
-
University of OsloGodthaab rehabilitation centreCompleted
-
Ostfold Hospital TrustUniversity of OsloCompleted
-
Boston Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedProtein Feeding in Post-traumatic Injury PatientsUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMalnutrition | Retroperitoneal Sarcoma
-
University Hospital, Clermont-FerrandDirection Générale de l'Offre de SoinsUnknownGastric Cancer | Oesophageal CancerFrance
-
Third Affiliated Hospital, Sun Yat-Sen UniversityRecruitingAcute-On-Chronic Liver Failure | Malnutrition | Nutrition Support | Hepatitis B,ChronicChina
-
Chungnam National University HospitalRecruitingSarcopeniaKorea, Republic of